Excedrin QuickTabs launch delay
This article was originally published in The Tan Sheet
Executive SummarySupplier manufacturing problems continue to postpone launch of Bristol-Myers Squibb's first "melt-in-your-mouth" pain reliever, firm says. Bristol is devising interim marketing plans for other Excedrin products, redesigning QuickTabs launch campaign. Current Excedrin ad agency Bozell Worldwide (New York) will handle QuickTabs market introduction. Product, which contains 500 mg acetaminophen, 65 mg caffeine, will be priced similarly with Excedrin Aspirin-Free and will come in 16- and 32-count sizes...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.